Publisher: Bentham Science Publishers
E-ISSN: 1875-533x|19|32|5572-5579
ISSN: 0929-8673
Source: Current Medicinal Chemistry, Vol.19, Iss.32, 2012-11, pp. : 5572-5579
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Genetic engineering of stem cells and their derivatives has the potential to enhance their regenerative capabilities. Here, dendrimer- and lipofection-based approaches were used for non-viral neurotrophin-3 (NT-3) over-expression in Schwann cells differentiated from skin precursors (SKP-SCs). A variety of dendrimers were first tested for transfection efficiency on HEK 293T cells, with PAMAMNH2 G4 found most effective and used subsequently for SKP-SCs transfection. Plasmid-based expression resulted in increased NT-3 release from SKP-SCs in both adherent and microcarrier-based culture. In a proof-of-concept study, the microcarrier/SKP-SCs were implanted into the injured nerve, and transfected cells were shown to detach, integrate into the nerve tissue and associate with regenerating axons. Virus-free systems for transient neurotrophin expression are a feasible and biologically safe option to increase the therapeutic value of stem cells and stem cell-derived cells in nerve repair strategies. Further work to develop bioprocesses for expansion of SKP-SCs on microcarriers in bioreactors is still needed.
Related content
Viral and Non-Viral Methods to Genetically Modify Dendritic Cells
Current Gene Therapy, Vol. 12, Iss. 2, 2012-04 ,pp. :
Non-Viral Gene Delivery to the Lungs
Current Gene Therapy, Vol. 5, Iss. 2, 2005-04 ,pp. :
Non-Viral Gene Delivery Methods
Current Pharmaceutical Biotechnology, Vol. 14, Iss. 1, 2013-01 ,pp. :